Intro to Fall Vaccine Guidance

COVID-19

Fall COVID-19 vaccines have an updated formula this season targeting either the JN.1 variant or the KP.2 variant, depending on the brand. Overall effectiveness is unknown at this time, but updated vaccines provided nearly 60% additional protection last fall.

Novavax, a traditional protein vaccine, is one option available. This method cannot be updated quite as quickly, so it's composition mainly targets the COVID-19 variant, JN.1. Data indicates that this does not pose an issue to fall protection since the JN.1 variant still prompts good immune responses against current COVID-19 strains. Pfizer and Moderna are offering a more up-to-date mRNA vaccine, which target the latest Omicron subvariants.

COVID-19 vaccines are available to everyone 6 months and older. If you were recently infected, general guidance states to wait 4-6 months. If you were not recently infected, general guidance recommends to get vaccinated at your earliest convenience.

Influenza

RSV